Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
No plan disclosedOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Feb 2026 and May 2026.
- Largest single sale: $320K (6,636 shares) of Bio-Techne on May 8, 2026. Filing
- Last sale before this period: Jun 9, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Bio-Techne (TECH) | Director | Feb 7, 2025 | Aug 19, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Aug 15, 2026, Bio-Techne: 589 shares vested; 213 shares withheld by the company for taxes (some held indirectly). 1 filing: 1
- May 8, 2026, Bio-Techne: sold 6,636 shares for $320K, no plan disclosed; 6,636 shares acquired by exercising options (some held indirectly). 1 filing: 1
- Feb 17, 2026, Bio-Techne: sold 1,976 shares for $117K, no plan disclosed (some held indirectly). 1 filing: 1
- Feb 3, 2026, Bio-Techne: 38 shares vested; 16 shares withheld by the company for taxes (some held indirectly). 1 filing: 1
- Oct 30, 2025, Bio-Techne: 1,640 shares awarded. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.